The global market for Antibodies for Research was valued at US$ 1620 million in the year 2024 and is projected to reach a revised size of US$ 2254 million by 2031, growing at a CAGR of 4.9% during the forecast period.

Antibodies for Research Market

Research antibodies are divided into monoclonal antibodies and polyclonal antibodies. Monoclonal antibodies, also called mAbs, are laboratory-made antibodies that bind to specific targets in the body, such as antigens on the surface of cancer cells. There are several types of monoclonal antibodies, and each mAb is designed to bind a single antigen. They can be used alone or in combination with other drugs to deliver drugs, toxins or radioactive substances directly to cancer cells.

Polyclonal antibody, also known as "polyclonal antibody" (Polyclonal Antibody), is an antibody mixture containing multiple types of antibodies. The "poly" in its name refers to the mixture of antibodies produced by different types of plasma cells.

Rising R&D activities in neurological, oncology, and stem cell research, increasing prevalence of cancer and infectious diseases, growing demand for antibodies, and increasing regulation across the biopharmaceutical industry are the key factors driving the research-based antibodies market revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Antibodies for Research, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antibodies for Research.

The Antibodies for Research market size, estimations, and forecasts are provided in terms of sales volume (mg) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Antibodies for Research market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Antibodies for Research manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Antibodies for Research Market Report

Report Metric	Details
Report Name	Antibodies for Research Market
Accounted market size in year	US$ 1620 million
Forecasted market size in 2031	US$ 2254 million
CAGR	4.9%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Monoclonal Polyclonal
Segment by Application	Oncology Neurobiology Immunology Others
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Merck, Johnson and Johnson Services, Eli Lilly and Company, Bio-Rad Laboratories, Inc, Cell Signalling Technology, PerkinEImer, Rockland Immunochemicals, Novartis, BD, Abcam, Kamiya Biomedical, AMSBIO, Thermo Fisher Scientific, GeneTex, MCE, Shanghai Yanmai Biotechnology, Shanghai LONG ISLAND Antibody Diagnostica, SUNSHINE GUOJIAN PHARMACEUTICAL, Shanghai Junshi Biosciences
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Antibodies for Research manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Antibodies for Research in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Antibodies for Research Market growing?

Ans: The Antibodies for Research Market witnessing a CAGR of 4.9% during the forecast period 2025-2031.

What is the Antibodies for Research Market size in 2031?

Ans: The Antibodies for Research Market size in 2031 will be US$ 2254 million.

Who are the main players in the Antibodies for Research Market report?

Ans: The main players in the Antibodies for Research Market are Merck, Johnson and Johnson Services, Eli Lilly and Company, Bio-Rad Laboratories, Inc, Cell Signalling Technology, PerkinEImer, Rockland Immunochemicals, Novartis, BD, Abcam, Kamiya Biomedical, AMSBIO, Thermo Fisher Scientific, GeneTex, MCE, Shanghai Yanmai Biotechnology, Shanghai LONG ISLAND Antibody Diagnostica, SUNSHINE GUOJIAN PHARMACEUTICAL, Shanghai Junshi Biosciences

What are the Application segmentation covered in the Antibodies for Research Market report?

Ans: The Applications covered in the Antibodies for Research Market report are Oncology, Neurobiology, Immunology, Others

What are the Type segmentation covered in the Antibodies for Research Market report?

Ans: The Types covered in the Antibodies for Research Market report are Monoclonal, Polyclonal

1 Antibodies for Research Market Overview

1.1 Product Definition

1.2 Antibodies for Research by Type

1.2.1 Global Antibodies for Research Market Value Comparison by Type (2024 VS 2031)

1.2.2 Monoclonal

1.2.3 Polyclonal

1.3 Antibodies for Research by Application

1.3.1 Global Antibodies for Research Market Value by Application (2024 VS 2031)

1.3.2 Oncology

1.3.3 Neurobiology

1.3.4 Immunology

1.3.5 Others

1.4 Global Antibodies for Research Market Size Estimates and Forecasts

1.4.1 Global Antibodies for Research Revenue 2020-2031

1.4.2 Global Antibodies for Research Sales 2020-2031

1.4.3 Global Antibodies for Research Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Antibodies for Research Market Competition by Manufacturers

2.1 Global Antibodies for Research Sales Market Share by Manufacturers (2020-2025)

2.2 Global Antibodies for Research Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Antibodies for Research Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Antibodies for Research, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Antibodies for Research, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Antibodies for Research, Product Type & Application

2.7 Global Key Manufacturers of Antibodies for Research, Date of Enter into This Industry

2.8 Global Antibodies for Research Market Competitive Situation and Trends

2.8.1 Global Antibodies for Research Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Antibodies for Research Players Market Share by Revenue

2.8.3 Global Antibodies for Research Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Antibodies for Research Market Scenario by Region

3.1 Global Antibodies for Research Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Antibodies for Research Sales by Region: 2020-2031

3.2.1 Global Antibodies for Research Sales by Region: 2020-2025

3.2.2 Global Antibodies for Research Sales by Region: 2026-2031

3.3 Global Antibodies for Research Revenue by Region: 2020-2031

3.3.1 Global Antibodies for Research Revenue by Region: 2020-2025

3.3.2 Global Antibodies for Research Revenue by Region: 2026-2031

3.4 North America Antibodies for Research Market Facts & Figures by Country

3.4.1 North America Antibodies for Research Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Antibodies for Research Sales by Country (2020-2031)

3.4.3 North America Antibodies for Research Revenue by Country (2020-2031)

3.4.4 United States

3.4.5 Canada

3.5 Europe Antibodies for Research Market Facts & Figures by Country

3.5.1 Europe Antibodies for Research Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Antibodies for Research Sales by Country (2020-2031)

3.5.3 Europe Antibodies for Research Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Antibodies for Research Market Facts & Figures by Region

3.6.1 Asia Pacific Antibodies for Research Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Antibodies for Research Sales by Region (2020-2031)

3.6.3 Asia Pacific Antibodies for Research Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Antibodies for Research Market Facts & Figures by Country

3.7.1 Latin America Antibodies for Research Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Antibodies for Research Sales by Country (2020-2031)

3.7.3 Latin America Antibodies for Research Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.7.7 Colombia

3.8 Middle East and Africa Antibodies for Research Market Facts & Figures by Country

3.8.1 Middle East and Africa Antibodies for Research Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Antibodies for Research Sales by Country (2020-2031)

3.8.3 Middle East and Africa Antibodies for Research Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Antibodies for Research Sales by Type (2020-2031)

4.1.1 Global Antibodies for Research Sales by Type (2020-2025)

4.1.2 Global Antibodies for Research Sales by Type (2026-2031)

4.1.3 Global Antibodies for Research Sales Market Share by Type (2020-2031)

4.2 Global Antibodies for Research Revenue by Type (2020-2031)

4.2.1 Global Antibodies for Research Revenue by Type (2020-2025)

4.2.2 Global Antibodies for Research Revenue by Type (2026-2031)

4.2.3 Global Antibodies for Research Revenue Market Share by Type (2020-2031)

4.3 Global Antibodies for Research Price by Type (2020-2031)

5 Segment by Application

5.1 Global Antibodies for Research Sales by Application (2020-2031)

5.1.1 Global Antibodies for Research Sales by Application (2020-2025)

5.1.2 Global Antibodies for Research Sales by Application (2026-2031)

5.1.3 Global Antibodies for Research Sales Market Share by Application (2020-2031)

5.2 Global Antibodies for Research Revenue by Application (2020-2031)

5.2.1 Global Antibodies for Research Revenue by Application (2020-2025)

5.2.2 Global Antibodies for Research Revenue by Application (2026-2031)

5.2.3 Global Antibodies for Research Revenue Market Share by Application (2020-2031)

5.3 Global Antibodies for Research Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Merck

6.1.1 Merck Company Information

6.1.2 Merck Description and Business Overview

6.1.3 Merck Antibodies for Research Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Merck Antibodies for Research Product Portfolio

6.1.5 Merck Recent Developments/Updates

6.2 Johnson and Johnson Services

6.2.1 Johnson and Johnson Services Company Information

6.2.2 Johnson and Johnson Services Description and Business Overview

6.2.3 Johnson and Johnson Services Antibodies for Research Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Johnson and Johnson Services Antibodies for Research Product Portfolio

6.2.5 Johnson and Johnson Services Recent Developments/Updates

6.3 Eli Lilly and Company

6.3.1 Eli Lilly and Company Company Information

6.3.2 Eli Lilly and Company Description and Business Overview

6.3.3 Eli Lilly and Company Antibodies for Research Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Eli Lilly and Company Antibodies for Research Product Portfolio

6.3.5 Eli Lilly and Company Recent Developments/Updates

6.4 Bio-Rad Laboratories, Inc

6.4.1 Bio-Rad Laboratories, Inc Company Information

6.4.2 Bio-Rad Laboratories, Inc Description and Business Overview

6.4.3 Bio-Rad Laboratories, Inc Antibodies for Research Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Bio-Rad Laboratories, Inc Antibodies for Research Product Portfolio

6.4.5 Bio-Rad Laboratories, Inc Recent Developments/Updates

6.5 Cell Signalling Technology

6.5.1 Cell Signalling Technology Company Information

6.5.2 Cell Signalling Technology Description and Business Overview

6.5.3 Cell Signalling Technology Antibodies for Research Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Cell Signalling Technology Antibodies for Research Product Portfolio

6.5.5 Cell Signalling Technology Recent Developments/Updates

6.6 PerkinEImer

6.6.1 PerkinEImer Company Information

6.6.2 PerkinEImer Description and Business Overview

6.6.3 PerkinEImer Antibodies for Research Sales, Revenue and Gross Margin (2020-2025)

6.6.4 PerkinEImer Antibodies for Research Product Portfolio

6.6.5 PerkinEImer Recent Developments/Updates

6.7 Rockland Immunochemicals

6.7.1 Rockland Immunochemicals Company Information

6.7.2 Rockland Immunochemicals Description and Business Overview

6.7.3 Rockland Immunochemicals Antibodies for Research Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Rockland Immunochemicals Antibodies for Research Product Portfolio

6.7.5 Rockland Immunochemicals Recent Developments/Updates

6.8 Novartis

6.8.1 Novartis Company Information

6.8.2 Novartis Description and Business Overview

6.8.3 Novartis Antibodies for Research Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Novartis Antibodies for Research Product Portfolio

6.8.5 Novartis Recent Developments/Updates

6.9 BD

6.9.1 BD Company Information

6.9.2 BD Description and Business Overview

6.9.3 BD Antibodies for Research Sales, Revenue and Gross Margin (2020-2025)

6.9.4 BD Antibodies for Research Product Portfolio

6.9.5 BD Recent Developments/Updates

6.10 Abcam

6.10.1 Abcam Company Information

6.10.2 Abcam Description and Business Overview

6.10.3 Abcam Antibodies for Research Sales, Revenue and Gross Margin (2020-2025)

6.10.4 Abcam Antibodies for Research Product Portfolio

6.10.5 Abcam Recent Developments/Updates

6.11 Kamiya Biomedical

6.11.1 Kamiya Biomedical Company Information

6.11.2 Kamiya Biomedical Description and Business Overview

6.11.3 Kamiya Biomedical Antibodies for Research Sales, Revenue and Gross Margin (2020-2025)

6.11.4 Kamiya Biomedical Antibodies for Research Product Portfolio

6.11.5 Kamiya Biomedical Recent Developments/Updates

6.12 AMSBIO

6.12.1 AMSBIO Company Information

6.12.2 AMSBIO Description and Business Overview

6.12.3 AMSBIO Antibodies for Research Sales, Revenue and Gross Margin (2020-2025)

6.12.4 AMSBIO Antibodies for Research Product Portfolio

6.12.5 AMSBIO Recent Developments/Updates

6.13 Thermo Fisher Scientific

6.13.1 Thermo Fisher Scientific Company Information

6.13.2 Thermo Fisher Scientific Description and Business Overview

6.13.3 Thermo Fisher Scientific Antibodies for Research Sales, Revenue and Gross Margin (2020-2025)

6.13.4 Thermo Fisher Scientific Antibodies for Research Product Portfolio

6.13.5 Thermo Fisher Scientific Recent Developments/Updates

6.14 GeneTex

6.14.1 GeneTex Company Information

6.14.2 GeneTex Description and Business Overview

6.14.3 GeneTex Antibodies for Research Sales, Revenue and Gross Margin (2020-2025)

6.14.4 GeneTex Antibodies for Research Product Portfolio

6.14.5 GeneTex Recent Developments/Updates

6.15 MCE

6.15.1 MCE Company Information

6.15.2 MCE Description and Business Overview

6.15.3 MCE Antibodies for Research Sales, Revenue and Gross Margin (2020-2025)

6.15.4 MCE Antibodies for Research Product Portfolio

6.15.5 MCE Recent Developments/Updates

6.16 Shanghai Yanmai Biotechnology

6.16.1 Shanghai Yanmai Biotechnology Company Information

6.16.2 Shanghai Yanmai Biotechnology Description and Business Overview

6.16.3 Shanghai Yanmai Biotechnology Antibodies for Research Sales, Revenue and Gross Margin (2020-2025)

6.16.4 Shanghai Yanmai Biotechnology Antibodies for Research Product Portfolio

6.16.5 Shanghai Yanmai Biotechnology Recent Developments/Updates

6.17 Shanghai LONG ISLAND Antibody Diagnostica

6.17.1 Shanghai LONG ISLAND Antibody Diagnostica Company Information

6.17.2 Shanghai LONG ISLAND Antibody Diagnostica Description and Business Overview

6.17.3 Shanghai LONG ISLAND Antibody Diagnostica Antibodies for Research Sales, Revenue and Gross Margin (2020-2025)

6.17.4 Shanghai LONG ISLAND Antibody Diagnostica Antibodies for Research Product Portfolio

6.17.5 Shanghai LONG ISLAND Antibody Diagnostica Recent Developments/Updates

6.18 SUNSHINE GUOJIAN PHARMACEUTICAL

6.18.1 SUNSHINE GUOJIAN PHARMACEUTICAL Company Information

6.18.2 SUNSHINE GUOJIAN PHARMACEUTICAL Description and Business Overview

6.18.3 SUNSHINE GUOJIAN PHARMACEUTICAL Antibodies for Research Sales, Revenue and Gross Margin (2020-2025)

6.18.4 SUNSHINE GUOJIAN PHARMACEUTICAL Antibodies for Research Product Portfolio

6.18.5 SUNSHINE GUOJIAN PHARMACEUTICAL Recent Developments/Updates

6.19 Shanghai Junshi Biosciences

6.19.1 Shanghai Junshi Biosciences Company Information

6.19.2 Shanghai Junshi Biosciences Description and Business Overview

6.19.3 Shanghai Junshi Biosciences Antibodies for Research Sales, Revenue and Gross Margin (2020-2025)

6.19.4 Shanghai Junshi Biosciences Antibodies for Research Product Portfolio

6.19.5 Shanghai Junshi Biosciences Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Antibodies for Research Industry Chain Analysis

7.2 Antibodies for Research Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Antibodies for Research Production Mode & Process Analysis

7.4 Antibodies for Research Sales and Marketing

7.4.1 Antibodies for Research Sales Channels

7.4.2 Antibodies for Research Distributors

7.5 Antibodies for Research Customer Analysis

8 Antibodies for Research Market Dynamics

8.1 Antibodies for Research Industry Trends

8.2 Antibodies for Research Market Drivers

8.3 Antibodies for Research Market Challenges

8.4 Antibodies for Research Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Merck

Johnson And Johnson Services

Eli Lilly and Company

Bio-Rad Laboratories Inc

Cell Signalling Technology

PerkinEImer

Rockland Immunochemicals

Thermo Fisher Scientific

GeneTex

MCE

Shanghai Junshi Biosciences

Shanghai Yanmai Biotechnology

Shanghai LONG ISLAND Antibody Diagnostica

SUNSHINE GUOJIAN PHARMACEUTICAL

List of Tables

Table 1. Global Antibodies for Research Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Antibodies for Research Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Antibodies for Research Market Competitive Situation by Manufacturers in 2024

Table 4. Global Antibodies for Research Sales (mg) of Key Manufacturers (2020-2025)

Table 5. Global Antibodies for Research Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Antibodies for Research Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Antibodies for Research Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Antibodies for Research Average Price (US$/mg) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Antibodies for Research, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Antibodies for Research, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Antibodies for Research, Product Type & Application

Table 12. Global Key Manufacturers of Antibodies for Research, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Antibodies for Research by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antibodies for Research as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Antibodies for Research Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Antibodies for Research Sales by Region (2020-2025) & (mg)

Table 18. Global Antibodies for Research Sales Market Share by Region (2020-2025)

Table 19. Global Antibodies for Research Sales by Region (2026-2031) & (mg)

Table 20. Global Antibodies for Research Sales Market Share by Region (2026-2031)

Table 21. Global Antibodies for Research Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Antibodies for Research Revenue Market Share by Region (2020-2025)

Table 23. Global Antibodies for Research Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Antibodies for Research Revenue Market Share by Region (2026-2031)

Table 25. North America Antibodies for Research Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Antibodies for Research Sales by Country (2020-2025) & (mg)

Table 27. North America Antibodies for Research Sales by Country (2026-2031) & (mg)

Table 28. North America Antibodies for Research Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Antibodies for Research Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Antibodies for Research Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Antibodies for Research Sales by Country (2020-2025) & (mg)

Table 32. Europe Antibodies for Research Sales by Country (2026-2031) & (mg)

Table 33. Europe Antibodies for Research Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Antibodies for Research Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Antibodies for Research Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Antibodies for Research Sales by Region (2020-2025) & (mg)

Table 37. Asia Pacific Antibodies for Research Sales by Region (2026-2031) & (mg)

Table 38. Asia Pacific Antibodies for Research Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Antibodies for Research Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Antibodies for Research Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Antibodies for Research Sales by Country (2020-2025) & (mg)

Table 42. Latin America Antibodies for Research Sales by Country (2026-2031) & (mg)

Table 43. Latin America Antibodies for Research Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Antibodies for Research Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Antibodies for Research Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Antibodies for Research Sales by Country (2020-2025) & (mg)

Table 47. Middle East and Africa Antibodies for Research Sales by Country (2026-2031) & (mg)

Table 48. Middle East and Africa Antibodies for Research Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Antibodies for Research Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Antibodies for Research Sales (mg) by Type (2020-2025)

Table 51. Global Antibodies for Research Sales (mg) by Type (2026-2031)

Table 52. Global Antibodies for Research Sales Market Share by Type (2020-2025)

Table 53. Global Antibodies for Research Sales Market Share by Type (2026-2031)

Table 54. Global Antibodies for Research Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Antibodies for Research Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Antibodies for Research Revenue Market Share by Type (2020-2025)

Table 57. Global Antibodies for Research Revenue Market Share by Type (2026-2031)

Table 58. Global Antibodies for Research Price (US$/mg) by Type (2020-2025)

Table 59. Global Antibodies for Research Price (US$/mg) by Type (2026-2031)

Table 60. Global Antibodies for Research Sales (mg) by Application (2020-2025)

Table 61. Global Antibodies for Research Sales (mg) by Application (2026-2031)

Table 62. Global Antibodies for Research Sales Market Share by Application (2020-2025)

Table 63. Global Antibodies for Research Sales Market Share by Application (2026-2031)

Table 64. Global Antibodies for Research Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Antibodies for Research Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Antibodies for Research Revenue Market Share by Application (2020-2025)

Table 67. Global Antibodies for Research Revenue Market Share by Application (2026-2031)

Table 68. Global Antibodies for Research Price (US$/mg) by Application (2020-2025)

Table 69. Global Antibodies for Research Price (US$/mg) by Application (2026-2031)

Table 70. Merck Company Information

Table 71. Merck Description and Business Overview

Table 72. Merck Antibodies for Research Sales (mg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)

Table 73. Merck Antibodies for Research Product

Table 74. Merck Recent Developments/Updates

Table 75. Johnson and Johnson Services Company Information

Table 76. Johnson and Johnson Services Description and Business Overview

Table 77. Johnson and Johnson Services Antibodies for Research Sales (mg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)

Table 78. Johnson and Johnson Services Antibodies for Research Product

Table 79. Johnson and Johnson Services Recent Developments/Updates

Table 80. Eli Lilly and Company Company Information

Table 81. Eli Lilly and Company Description and Business Overview

Table 82. Eli Lilly and Company Antibodies for Research Sales (mg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)

Table 83. Eli Lilly and Company Antibodies for Research Product

Table 84. Eli Lilly and Company Recent Developments/Updates

Table 85. Bio-Rad Laboratories, Inc Company Information

Table 86. Bio-Rad Laboratories, Inc Description and Business Overview

Table 87. Bio-Rad Laboratories, Inc Antibodies for Research Sales (mg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)

Table 88. Bio-Rad Laboratories, Inc Antibodies for Research Product

Table 89. Bio-Rad Laboratories, Inc Recent Developments/Updates

Table 90. Cell Signalling Technology Company Information

Table 91. Cell Signalling Technology Description and Business Overview

Table 92. Cell Signalling Technology Antibodies for Research Sales (mg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)

Table 93. Cell Signalling Technology Antibodies for Research Product

Table 94. Cell Signalling Technology Recent Developments/Updates

Table 95. PerkinEImer Company Information

Table 96. PerkinEImer Description and Business Overview

Table 97. PerkinEImer Antibodies for Research Sales (mg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)

Table 98. PerkinEImer Antibodies for Research Product

Table 99. PerkinEImer Recent Developments/Updates

Table 100. Rockland Immunochemicals Company Information

Table 101. Rockland Immunochemicals Description and Business Overview

Table 102. Rockland Immunochemicals Antibodies for Research Sales (mg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)

Table 103. Rockland Immunochemicals Antibodies for Research Product

Table 104. Rockland Immunochemicals Recent Developments/Updates

Table 105. Novartis Company Information

Table 106. Novartis Description and Business Overview

Table 107. Novartis Antibodies for Research Sales (mg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)

Table 108. Novartis Antibodies for Research Product

Table 109. Novartis Recent Developments/Updates

Table 110. BD Company Information

Table 111. BD Description and Business Overview

Table 112. BD Antibodies for Research Sales (mg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)

Table 113. BD Antibodies for Research Product

Table 114. BD Recent Developments/Updates

Table 115. Abcam Company Information

Table 116. Abcam Description and Business Overview

Table 117. Abcam Antibodies for Research Sales (mg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)

Table 118. Abcam Antibodies for Research Product

Table 119. Abcam Recent Developments/Updates

Table 120. Kamiya Biomedical Company Information

Table 121. Kamiya Biomedical Description and Business Overview

Table 122. Kamiya Biomedical Antibodies for Research Sales (mg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)

Table 123. Kamiya Biomedical Antibodies for Research Product

Table 124. Kamiya Biomedical Recent Developments/Updates

Table 125. AMSBIO Company Information

Table 126. AMSBIO Description and Business Overview

Table 127. AMSBIO Antibodies for Research Sales (mg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)

Table 128. AMSBIO Antibodies for Research Product

Table 129. AMSBIO Recent Developments/Updates

Table 130. Thermo Fisher Scientific Company Information

Table 131. Thermo Fisher Scientific Description and Business Overview

Table 132. Thermo Fisher Scientific Antibodies for Research Sales (mg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)

Table 133. Thermo Fisher Scientific Antibodies for Research Product

Table 134. Thermo Fisher Scientific Recent Developments/Updates

Table 135. GeneTex Company Information

Table 136. GeneTex Description and Business Overview

Table 137. GeneTex Antibodies for Research Sales (mg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)

Table 138. GeneTex Antibodies for Research Product

Table 139. GeneTex Recent Developments/Updates

Table 140. MCE Company Information

Table 141. MCE Description and Business Overview

Table 142. MCE Antibodies for Research Sales (mg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)

Table 143. MCE Antibodies for Research Product

Table 144. MCE Recent Developments/Updates

Table 145. Shanghai Yanmai Biotechnology Company Information

Table 146. Shanghai Yanmai Biotechnology Description and Business Overview

Table 147. Shanghai Yanmai Biotechnology Antibodies for Research Sales (mg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)

Table 148. Shanghai Yanmai Biotechnology Antibodies for Research Product

Table 149. Shanghai Yanmai Biotechnology Recent Developments/Updates

Table 150. Shanghai LONG ISLAND Antibody Diagnostica Company Information

Table 151. Shanghai LONG ISLAND Antibody Diagnostica Description and Business Overview

Table 152. Shanghai LONG ISLAND Antibody Diagnostica Antibodies for Research Sales (mg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)

Table 153. Shanghai LONG ISLAND Antibody Diagnostica Antibodies for Research Product

Table 154. Shanghai LONG ISLAND Antibody Diagnostica Recent Developments/Updates

Table 155. SUNSHINE GUOJIAN PHARMACEUTICAL Company Information

Table 156. SUNSHINE GUOJIAN PHARMACEUTICAL Description and Business Overview

Table 157. SUNSHINE GUOJIAN PHARMACEUTICAL Antibodies for Research Sales (mg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)

Table 158. SUNSHINE GUOJIAN PHARMACEUTICAL Antibodies for Research Product

Table 159. SUNSHINE GUOJIAN PHARMACEUTICAL Recent Developments/Updates

Table 160. Shanghai Junshi Biosciences Company Information

Table 161. Shanghai Junshi Biosciences Description and Business Overview

Table 162. Shanghai Junshi Biosciences Antibodies for Research Sales (mg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)

Table 163. Shanghai Junshi Biosciences Antibodies for Research Product

Table 164. Shanghai Junshi Biosciences Recent Developments/Updates

Table 165. Key Raw Materials Lists

Table 166. Raw Materials Key Suppliers Lists

Table 167. Antibodies for Research Distributors List

Table 168. Antibodies for Research Customers List

Table 169. Antibodies for Research Market Trends

Table 170. Antibodies for Research Market Drivers

Table 171. Antibodies for Research Market Challenges

Table 172. Antibodies for Research Market Restraints

Table 173. Research Programs/Design for This Report

Table 174. Key Data Information from Secondary Sources

Table 175. Key Data Information from Primary Sources

Table 176. Authors List of This Report

List of Figures

Figure 1. Product Picture of Antibodies for Research

Figure 2. Global Antibodies for Research Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Antibodies for Research Market Share by Type: 2024 & 2031

Figure 4. Monoclonal Product Picture

Figure 5. Polyclonal Product Picture

Figure 6. Global Antibodies for Research Market Value by Application (2020-2031) & (US$ Million)

Figure 7. Global Antibodies for Research Market Share by Application: 2024 & 2031

Figure 8. Oncology

Figure 9. Neurobiology

Figure 10. Immunology

Figure 11. Others

Figure 12. Global Antibodies for Research Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 13. Global Antibodies for Research Market Size (2020-2031) & (US$ Million)

Figure 14. Global Antibodies for Research Sales (2020-2031) & (mg)

Figure 15. Global Antibodies for Research Average Price (US$/mg) & (2020-2031)

Figure 16. Antibodies for Research Report Years Considered

Figure 17. Antibodies for Research Sales Share by Manufacturers in 2024

Figure 18. Global Antibodies for Research Revenue Share by Manufacturers in 2024

Figure 19. Global 5 and 10 Largest Antibodies for Research Players: Market Share by Revenue in Antibodies for Research in 2024

Figure 20. Antibodies for Research Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 21. Global Antibodies for Research Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 22. North America Antibodies for Research Sales Market Share by Country (2020-2031)

Figure 23. North America Antibodies for Research Revenue Market Share by Country (2020-2031)

Figure 24. United States Antibodies for Research Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 25. Canada Antibodies for Research Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 26. Europe Antibodies for Research Sales Market Share by Country (2020-2031)

Figure 27. Europe Antibodies for Research Revenue Market Share by Country (2020-2031)

Figure 28. Germany Antibodies for Research Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. France Antibodies for Research Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. U.K. Antibodies for Research Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. Italy Antibodies for Research Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Russia Antibodies for Research Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 33. Asia Pacific Antibodies for Research Sales Market Share by Region (2020-2031)

Figure 34. Asia Pacific Antibodies for Research Revenue Market Share by Region (2020-2031)

Figure 35. China Antibodies for Research Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. Japan Antibodies for Research Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. South Korea Antibodies for Research Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. India Antibodies for Research Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. Australia Antibodies for Research Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. China Taiwan Antibodies for Research Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Southeast Asia Antibodies for Research Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Latin America Antibodies for Research Sales Market Share by Country (2020-2031)

Figure 43. Latin America Antibodies for Research Revenue Market Share by Country (2020-2031)

Figure 44. Mexico Antibodies for Research Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Brazil Antibodies for Research Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Argentina Antibodies for Research Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Colombia Antibodies for Research Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 48. Middle East and Africa Antibodies for Research Sales Market Share by Country (2020-2031)

Figure 49. Middle East and Africa Antibodies for Research Revenue Market Share by Country (2020-2031)

Figure 50. Turkey Antibodies for Research Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. Saudi Arabia Antibodies for Research Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 52. UAE Antibodies for Research Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 53. Global Sales Market Share of Antibodies for Research by Type (2020-2031)

Figure 54. Global Revenue Market Share of Antibodies for Research by Type (2020-2031)

Figure 55. Global Antibodies for Research Price (US$/mg) by Type (2020-2031)

Figure 56. Global Sales Market Share of Antibodies for Research by Application (2020-2031)

Figure 57. Global Revenue Market Share of Antibodies for Research by Application (2020-2031)

Figure 58. Global Antibodies for Research Price (US$/mg) by Application (2020-2031)

Figure 59. Antibodies for Research Value Chain

Figure 60. Channels of Distribution (Direct Vs Distribution)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions